Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia

Achondroplasia (ACH) is a rare autosomal-dominant genetic disease resulting from a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. It is characterized by asymmetric short stature. Spinal stenosis and thoracolumbar kyphosis (TLK) are common findings in ACH patients. Severe TLK can e...

Full description

Bibliographic Details
Main Authors: LIU Fuze, WANG Hai
Format: Article
Language:zho
Published: Editorial Office of Journal of Rare Diseases 2023-10-01
Series:罕见病研究
Subjects:
Online Access:https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.04.004
_version_ 1797370243913351168
author LIU Fuze
WANG Hai
author_facet LIU Fuze
WANG Hai
author_sort LIU Fuze
collection DOAJ
description Achondroplasia (ACH) is a rare autosomal-dominant genetic disease resulting from a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. It is characterized by asymmetric short stature. Spinal stenosis and thoracolumbar kyphosis (TLK) are common findings in ACH patients. Severe TLK can exacerbate spinal stenosis, leading to neurological complications. This paper provides a brief review of the pathophysiological mechanisms, clinical characteristics, and treatments for spinal stenosis and TLK in ACH patients. Recently, three new drugs targeting FGFR3; vosoritide, recifercept, and infigratinib, have completed or are undergoing clinical trials. They have shown promising preliminary results in preventing spinal stenosis and TLK.
first_indexed 2024-03-08T17:58:36Z
format Article
id doaj.art-c0f2fcceaa624ddbbf87c287cd4fb951
institution Directory Open Access Journal
issn 2097-0501
language zho
last_indexed 2024-03-08T17:58:36Z
publishDate 2023-10-01
publisher Editorial Office of Journal of Rare Diseases
record_format Article
series 罕见病研究
spelling doaj.art-c0f2fcceaa624ddbbf87c287cd4fb9512024-01-02T03:18:14ZzhoEditorial Office of Journal of Rare Diseases罕见病研究2097-05012023-10-012448349110.12376/j.issn.2097-0501.2023.04.004Spinal Stenosis and Thoracolumbar Kyphosis in AchondroplasiaLIU FuzeWANG HaiAchondroplasia (ACH) is a rare autosomal-dominant genetic disease resulting from a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. It is characterized by asymmetric short stature. Spinal stenosis and thoracolumbar kyphosis (TLK) are common findings in ACH patients. Severe TLK can exacerbate spinal stenosis, leading to neurological complications. This paper provides a brief review of the pathophysiological mechanisms, clinical characteristics, and treatments for spinal stenosis and TLK in ACH patients. Recently, three new drugs targeting FGFR3; vosoritide, recifercept, and infigratinib, have completed or are undergoing clinical trials. They have shown promising preliminary results in preventing spinal stenosis and TLK.https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.04.004spinal stenosisthoracolumbar kyphosisachondroplasiafibroblast growth factor receptor-3
spellingShingle LIU Fuze
WANG Hai
Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
罕见病研究
spinal stenosis
thoracolumbar kyphosis
achondroplasia
fibroblast growth factor receptor-3
title Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
title_full Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
title_fullStr Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
title_full_unstemmed Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
title_short Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
title_sort spinal stenosis and thoracolumbar kyphosis in achondroplasia
topic spinal stenosis
thoracolumbar kyphosis
achondroplasia
fibroblast growth factor receptor-3
url https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.04.004
work_keys_str_mv AT liufuze spinalstenosisandthoracolumbarkyphosisinachondroplasia
AT wanghai spinalstenosisandthoracolumbarkyphosisinachondroplasia